PubMed:33020340
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T1 | 382-387 | Body_part | denotes | heart | http://purl.org/sig/ont/fma/fma7088 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T1 | 382-387 | Body_part | denotes | heart | http://purl.obolibrary.org/obo/UBERON_0000948 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 26-36 | Disease | denotes | Arrhythmia | http://purl.obolibrary.org/obo/MONDO_0007263 |
T2 | 41-61 | Disease | denotes | Sudden Cardiac Death | http://purl.obolibrary.org/obo/MONDO_0007264 |
T3 | 65-73 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T4 | 138-146 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T5 | 294-310 | Disease | denotes | Viral infections | http://purl.obolibrary.org/obo/MONDO_0005108 |
T6 | 323-347 | Disease | denotes | acute coronary syndromes | http://purl.obolibrary.org/obo/MONDO_0005542 |
T7 | 349-360 | Disease | denotes | arrhythmias | http://purl.obolibrary.org/obo/MONDO_0007263 |
T8 | 382-395 | Disease | denotes | heart failure | http://purl.obolibrary.org/obo/MONDO_0005252 |
T9 | 506-534 | Disease | denotes | inflammation at the arterial | http://purl.obolibrary.org/obo/MONDO_0043494 |
T10 | 506-518 | Disease | denotes | inflammation | http://purl.obolibrary.org/obo/MONDO_0021166 |
T11 | 688-696 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T12 | 965-973 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T13 | 1000-1009 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 147-150 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T2 | 183-186 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T3 | 194-195 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T4 | 240-245 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T5 | 246-249 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T6 | 258-259 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T7 | 382-387 | http://purl.obolibrary.org/obo/UBERON_0000948 | denotes | heart |
T8 | 382-387 | http://purl.obolibrary.org/obo/UBERON_0007100 | denotes | heart |
T9 | 382-387 | http://purl.obolibrary.org/obo/UBERON_0015228 | denotes | heart |
T10 | 382-387 | http://www.ebi.ac.uk/efo/EFO_0000815 | denotes | heart |
T11 | 404-405 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T12 | 526-534 | http://purl.obolibrary.org/obo/UBERON_0001637 | denotes | arterial |
T13 | 526-534 | http://www.ebi.ac.uk/efo/EFO_0000814 | denotes | arterial |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T1 | 601-608 | Chemical | denotes | hydroxy | http://purl.obolibrary.org/obo/CHEBI_43176 |
T2 | 609-620 | Chemical | denotes | chloroquine | http://purl.obolibrary.org/obo/CHEBI_3638 |
T3 | 650-662 | Chemical | denotes | azithromycin | http://purl.obolibrary.org/obo/CHEBI_2955 |
T4 | 707-718 | Chemical | denotes | chloroquine | http://purl.obolibrary.org/obo/CHEBI_3638 |
T5 | 720-738 | Chemical | denotes | hydroxychloroquine | http://purl.obolibrary.org/obo/CHEBI_5801 |
T6 | 744-756 | Chemical | denotes | azithromycin | http://purl.obolibrary.org/obo/CHEBI_2955 |
T7 | 941-950 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 294-310 | http://purl.obolibrary.org/obo/GO_0016032 | denotes | Viral infections |
T2 | 460-482 | http://purl.obolibrary.org/obo/GO_0006954 | denotes | inflammatory responses |
T3 | 506-518 | http://purl.obolibrary.org/obo/GO_0006954 | denotes | inflammation |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
4 | 14-36 | Disease | denotes | Ventricular Arrhythmia | MESH:D001145 |
5 | 48-61 | Disease | denotes | Cardiac Death | MESH:D003643 |
6 | 65-73 | Disease | denotes | COVID-19 | MESH:C000657245 |
7 | 74-82 | Species | denotes | Patients | Tax:9606 |
23 | 138-146 | Disease | denotes | COVID-19 | MESH:C000657245 |
24 | 294-310 | Disease | denotes | Viral infections | MESH:D001102 |
25 | 349-360 | Disease | denotes | arrhythmias | MESH:D001145 |
26 | 382-395 | Disease | denotes | heart failure | MESH:D006333 |
27 | 487-518 | Disease | denotes | localized vascular inflammation | MESH:D007249 |
28 | 600-620 | Chemical | denotes | (hydroxy)chloroquine | MESH:D006886 |
29 | 650-662 | Chemical | denotes | azithromycin | MESH:D017963 |
30 | 688-696 | Disease | denotes | COVID-19 | MESH:C000657245 |
31 | 707-718 | Chemical | denotes | chloroquine | MESH:D002738 |
32 | 720-738 | Chemical | denotes | hydroxychloroquine | MESH:D006886 |
33 | 744-756 | Chemical | denotes | azithromycin | MESH:D017963 |
34 | 821-837 | Disease | denotes | arrhythmic death | MESH:D003643 |
35 | 965-973 | Disease | denotes | COVID-19 | MESH:C000657245 |
36 | 1000-1009 | Disease | denotes | infection | MESH:D007239 |
37 | 1013-1019 | Species | denotes | people | Tax:9606 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-83 | Sentence | denotes | Prevention of Ventricular Arrhythmia and Sudden Cardiac Death in COVID-19 Patients. |
T2 | 84-205 | Sentence | denotes | Since the first case was reported at the end of 2019, COVID-19 has spread throughout the world and has become a pandemic. |
T3 | 206-293 | Sentence | denotes | The high transmission rate of the virus has made it a threat to public health globally. |
T4 | 294-548 | Sentence | denotes | Viral infections may trigger acute coronary syndromes, arrhythmias, and exacerbation of heart failure, due to a combination of effects including significant systemic inflammatory responses and localized vascular inflammation at the arterial plaque level. |
T5 | 549-697 | Sentence | denotes | Indonesian clinical practice guideline stated that (hydroxy)chloroquine alone or in combination with azithromycin may be used to treat for COVID-19. |
T6 | 698-893 | Sentence | denotes | However, chloroquine, hydroxychloroquine, and azithromycin all prolong the QT interval, raising concerns about the risk of arrhythmic death from individual or concurrent use of these medications. |
T7 | 894-974 | Sentence | denotes | To date, there is still no vaccine or specific antiviral treatment for COVID-19. |
T8 | 975-1109 | Sentence | denotes | Therefore, prevention of infection in people with cardiovascular risk and mitigation of the adverse effects of treatment is necessary. |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T1 | 14-36 | Phenotype | denotes | Ventricular Arrhythmia | http://purl.obolibrary.org/obo/HP_0004308 |
T2 | 41-61 | Phenotype | denotes | Sudden Cardiac Death | http://purl.obolibrary.org/obo/HP_0001645 |
T3 | 349-360 | Phenotype | denotes | arrhythmias | http://purl.obolibrary.org/obo/HP_0011675 |
T4 | 382-395 | Phenotype | denotes | heart failure | http://purl.obolibrary.org/obo/HP_0001635 |
T5 | 761-784 | Phenotype | denotes | prolong the QT interval | http://purl.obolibrary.org/obo/HP_0001657 |
hydroxychloroquine
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T1 | 14-36 | Phenotype | denotes | Ventricular Arrhythmia | http://purl.obolibrary.org/obo/HP_0004308 |
T2 | 41-61 | Phenotype | denotes | Sudden Cardiac Death | http://purl.obolibrary.org/obo/HP_0001645 |
T3 | 349-360 | Phenotype | denotes | arrhythmias | http://purl.obolibrary.org/obo/HP_0011675 |
T4 | 382-395 | Phenotype | denotes | heart failure | http://purl.obolibrary.org/obo/HP_0001635 |
T5 | 761-784 | Phenotype | denotes | prolong the QT interval | http://purl.obolibrary.org/obo/HP_0001657 |
Inflammaging
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-83 | Sentence | denotes | Prevention of Ventricular Arrhythmia and Sudden Cardiac Death in COVID-19 Patients. |
T2 | 84-205 | Sentence | denotes | Since the first case was reported at the end of 2019, COVID-19 has spread throughout the world and has become a pandemic. |
T3 | 206-293 | Sentence | denotes | The high transmission rate of the virus has made it a threat to public health globally. |
T4 | 294-548 | Sentence | denotes | Viral infections may trigger acute coronary syndromes, arrhythmias, and exacerbation of heart failure, due to a combination of effects including significant systemic inflammatory responses and localized vascular inflammation at the arterial plaque level. |
T5 | 549-697 | Sentence | denotes | Indonesian clinical practice guideline stated that (hydroxy)chloroquine alone or in combination with azithromycin may be used to treat for COVID-19. |
T6 | 698-893 | Sentence | denotes | However, chloroquine, hydroxychloroquine, and azithromycin all prolong the QT interval, raising concerns about the risk of arrhythmic death from individual or concurrent use of these medications. |
T7 | 894-974 | Sentence | denotes | To date, there is still no vaccine or specific antiviral treatment for COVID-19. |
T8 | 975-1109 | Sentence | denotes | Therefore, prevention of infection in people with cardiovascular risk and mitigation of the adverse effects of treatment is necessary. |
T1 | 0-83 | Sentence | denotes | Prevention of Ventricular Arrhythmia and Sudden Cardiac Death in COVID-19 Patients. |
T2 | 84-205 | Sentence | denotes | Since the first case was reported at the end of 2019, COVID-19 has spread throughout the world and has become a pandemic. |
T3 | 206-293 | Sentence | denotes | The high transmission rate of the virus has made it a threat to public health globally. |
T4 | 294-548 | Sentence | denotes | Viral infections may trigger acute coronary syndromes, arrhythmias, and exacerbation of heart failure, due to a combination of effects including significant systemic inflammatory responses and localized vascular inflammation at the arterial plaque level. |
T5 | 549-697 | Sentence | denotes | Indonesian clinical practice guideline stated that (hydroxy)chloroquine alone or in combination with azithromycin may be used to treat for COVID-19. |
T6 | 698-893 | Sentence | denotes | However, chloroquine, hydroxychloroquine, and azithromycin all prolong the QT interval, raising concerns about the risk of arrhythmic death from individual or concurrent use of these medications. |
T7 | 894-974 | Sentence | denotes | To date, there is still no vaccine or specific antiviral treatment for COVID-19. |
T8 | 975-1109 | Sentence | denotes | Therefore, prevention of infection in people with cardiovascular risk and mitigation of the adverse effects of treatment is necessary. |